查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2150263

Esomeprazole鎂腸溶片市場：全球市場預測，2026-2032年

Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，Esomeprazole腸溶片市場將成長至 7.9836 億美元，複合年成長率為 10.63%。

主要市場統計數據
基準年 2025 3.9354億美元
預計年份：2026年 4.4477億美元
預測年份 2032 7.9836億美元
複合年成長率 (%) 10.63%

Esomeprazole鎂腸溶片：概述

Esomeprazole腸溶片是一種口服質子幫浦阻斷劑，旨在抑制胃酸分泌。其腸溶包衣可防止活性成分在胃中分解，並促進藥物到達小腸。臨床上常用於治療與酸相關的疾病，例如胃食道逆流、糜爛性食道炎和某些潰瘍治療方案，但這些用途應遵循當地的核准情況、處方資訊和專業指導。

治療途徑的改變和藥物選擇的優先順序

治療方案正受到日益重視的因素影響，這些因素包括合理使用抑酸劑、提高用藥依從性、定期評估用藥狀態、個別化風險評估。雖然腸溶片在適宜口服給藥的情況下仍然重要，但醫療機構越來越強調明確的適應症、適當的給藥療程、在臨床合理的情況下停藥以及避免不必要的多重用藥。生產方面的重點包括劑量均勻性、包衣性能、穩定性、包裝完整性以及活性成分和成品的可靠供應。

人工智慧可以增強證據、提高品質和改善患者支援。

人工智慧 (AI) 可透過檢測藥物安全監測訊號、自動化科學和監管文件、分析需求和庫存以及識別潛在的品質偏差來支援該產品領域。在臨床工作流程中，決策支援工具可協助藥物配對、識別交互作用和重複給藥的風險，並提供個人化的用藥依從性介入措施。這些應用需要檢驗的資料集、人工監督、透明的管治、隱私保護以及防止自動化偏差的控制措施。人工智慧應作為處方決策和監管課責的補充，而非替代。

六個醫療保健環境的區域洞察

在北美，成熟的臨床指南、規範的藥品通路以及對質子幫浦阻斷劑長期使用的嚴格監測相結合。在歐洲，除了國家報銷和處方政策外，還強調統一的品質標準。亞太地區的特點是監管體系、生產能力和取得條件高度多樣化，品牌藥、學名藥、醫院和零售商的供應管道各不相同。拉丁美洲的特徵是公私醫療保健結構多元化，各國的醫療服務可近性水準也存在差異。在中東，採購模式多種多樣，在一些市場中，中央機構扮演重要角色。同時，非洲的需求與可負擔性、基本藥物的可近性、可靠的分銷和診斷能力密切相關。

東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約的集團層級優先事項

在東協，各國在監管協調、私人零售通路以及藥品准入條件方面存在差異。金磚國家成員國在國內藥品生產、公共採購和監管執行方面也存在顯著差異。歐盟受益於通用的法律規範，同時在報銷機制和處方實踐方面保持國家差異。七國集團體系通常高度重視實證標準、藥物安全監測和抑酸治療的管理。海灣合作理事會國家通常將集中採購與私營部門分銷結合。同時，北約成員國的醫療保健體系各不相同，雖然在某些情況下，國防相關醫療用品的供應可能很重要，但這並不能取代國家民用醫療保健需求。

關於取得和使用方面的具體國家/地區考量因素

澳洲和加拿大擁有成熟的監管和報銷框架，同時確保合理的處方和便利的藥房服務。巴西、墨西哥和印度則需要應對多元化的公共和私人通路、區域性藥品獲取差異以及當地的監管要求。中國、日本和韓國擁有先進的醫療基礎設施，並結合了各自獨特的批准、報銷和臨床實踐系統。法國、德國、義大利、西班牙和英國高度重視實證醫學、安全監測以及國家或地區醫療機構政策。俄羅斯的藥品環境需要進行針對該國的監管、採購、物流和合規性評估。在所有上述國家，產品標籤、處方規範、品質標準和治療指南都必須在當地進行核實。

給經營團隊的建議：加強品質、管理與可近

產業領導者必須對活性成分的採購、包衣性能、溶離度、穩定性、序列化（如適用）以及申訴處理進行嚴格管控。他們還應確保醫療和商業活動與已批准的適應症保持一致，提供清晰的給藥方法和療程指導，並透過醫療保健專業人員支持負責任的停藥溝通。產品系列和供應決策應考慮公共採購、藥房分銷、本地註冊和緊急時應對計畫。數位化和人工智慧投資應從嚴格定義且可衡量的應用案例入手，並透過檢驗、網路安全、隱私保護和人工審核進行管理。持續監測安全訊息傳播、指南變更和各國具體要求至關重要。

調查方法：對產品、臨床和監管因素進行結構化審查。

本執行摘要採用定性綜合框架，重點關注Esomeprazole腸溶片的劑型、治療作用、醫療保健環境和運作要求。評估按地區、跨國公司集團和國家/地區進行組織，檢視製劑品質、臨床管理、取得途徑、供應彈性、藥物警戒和負責任的技術應用。本摘要未使用任何市場估計值、市場規模、市場佔有率、預測或公司特定聲明。針對特定國家的結論僅供參考，應根據當地的附加檔、處方集手冊、監管檢驗、治療指南和採購法規檢驗。

結論：負責任的交付仍是核心差異化因素。

Esomeprazole腸溶片在酸相關疾病的治療中發揮重要作用，但其成功應用不僅取決於藥物的可及性。在不同的醫療保健系統中，品質的一致性、患者的合理選擇、用藥依從性支持、劑量週期審查、藥物安全監測以及健全的配送系統都是至關重要的。應對區域和國家差異需要製定本地化的法規和准入策略，而人工智慧與實證醫學、課責和人工管理相結合，有助於改善監測系統。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：Esomeprazole腸溶片市場：依給藥途徑分類

  • 靜脈
  • 口服

第8章：Esomeprazole鎂腸溶片市場：依劑量強度分類

  • 10 mg
  • 20 mg
  • 40 mg

第9章：Esomeprazole腸溶片市場：以劑型分類

  • 膠囊
  • 藥片

第10章：Esomeprazole腸溶片市場：依應用領域分類

  • 胃食道逆流症
    • 侵蝕
    • 非侵蝕性
  • 消化性潰瘍
    • 十二指腸潰瘍
    • 胃潰瘍
  • 柔林格症候群

第11章：Esomeprazole腸溶片市場：依通路分類

  • 醫院藥房
    • 私立醫院
    • 公立醫院
  • 網路藥房
    • 電子商務平台
    • 遠距藥事照護
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第12章：Esomeprazole腸溶片市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：Esomeprazole腸溶片市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：Esomeprazole腸溶片市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • AstraZeneca PLC
  • Aurobindo Pharma Ltd.
  • Cadila Pharmaceuticals Ltd.（Zydus Cadila）
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.

第17章 主要專家

Product Code: MRR-3D150775FB38

The Esomeprazole Magnesium Enteric-coated Tablets Market is projected to grow by USD 798.36 million at a CAGR of 10.63% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 393.54 million
Estimated Year [2026] USD 444.77 million
Forecast Year [2032] USD 798.36 million
CAGR (%) 10.63%

Esomeprazole Magnesium Enteric-Coated Tablets: Executive Overview

Esomeprazole magnesium enteric-coated tablets are oral proton pump inhibitor medicines designed to reduce gastric acid secretion. Their enteric coating helps protect the active ingredient from degradation in the stomach and supports delivery to the small intestine. Clinical use commonly includes acid-related disorders such as gastroesophageal reflux disease, erosive esophagitis, and selected ulcer-management regimens, subject to local authorization, prescribing information, and professional guidance.

Shifting Treatment Pathways and Formulation Priorities

The treatment landscape is being shaped by greater attention to appropriate acid-suppression use, adherence, medication review, and patient-specific risk assessment. Enteric-coated tablet formats remain relevant where oral administration is suitable, while healthcare systems increasingly emphasize clear indications, appropriate duration, deprescribing when clinically justified, and avoidance of unnecessary polypharmacy. Manufacturing priorities include dosage consistency, coating performance, stability, packaging integrity, and reliable supply of active pharmaceutical ingredients and finished products.

Artificial Intelligence Strengthens Evidence, Quality, and Patient Support

Artificial intelligence can support this product area through pharmacovigilance signal detection, automated review of scientific and regulatory documents, demand and inventory analytics, and identification of potential quality deviations. In clinical workflows, decision-support tools may help reconcile medicines, flag interaction or duplication risks, and personalize adherence interventions. These applications require validated datasets, human oversight, transparent governance, privacy safeguards, and controls against automation bias; AI should complement rather than replace prescribing judgment and regulatory accountability.

Regional Insights Across Six Healthcare Environments

North America combines mature clinical guidance, regulated pharmacy channels, and strong scrutiny of long-term proton pump inhibitor use. Europe emphasizes harmonized quality expectations alongside national reimbursement and prescribing policies. Asia-Pacific includes highly varied regulatory systems, manufacturing capabilities, and access conditions, creating differing pathways for branded, generic, hospital, and retail supply. Latin America is characterized by diverse public-private healthcare structures and uneven access across countries. The Middle East shows varied procurement models and a strong role for centralized institutions in several markets, while Africa's requirements are closely linked to affordability, essential-medicine availability, distribution reliability, and diagnostic capacity.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN presents a mix of regulatory harmonization efforts, private retail channels, and differing national access conditions. BRICS members reflect substantial variation in domestic pharmaceutical production, public procurement, and regulatory implementation. The European Union benefits from shared regulatory structures while retaining national differences in reimbursement and prescribing practice. G7 systems generally place strong emphasis on evidence standards, pharmacovigilance, and stewardship of acid-suppressing therapy. GCC countries often combine centralized procurement with private-sector distribution, whereas NATO membership spans distinct health systems; defense-related medical supply considerations may matter in some settings but do not replace national civil-health requirements.

Country-Level Considerations for Access and Use

Australia and Canada operate within mature regulatory and reimbursement frameworks, with attention to appropriate prescribing and pharmacy access. Brazil, Mexico, and India require navigation of diverse public and private channels, regional access differences, and local regulatory requirements. China, Japan, and South Korea combine sophisticated healthcare infrastructure with distinct approval, reimbursement, and clinical-practice systems. France, Germany, Italy, Spain, and the United Kingdom place significant weight on evidence, safety monitoring, and national or regional health-system policies. Russia's pharmaceutical environment requires country-specific regulatory, procurement, logistics, and compliance assessment. Across all listed countries, product labeling, prescription status, quality standards, and treatment guidance should be verified locally.

Actions for Leaders: Strengthen Quality, Stewardship, and Access

Industry leaders should maintain robust control of active-ingredient sourcing, coating performance, dissolution, stability, serialization where applicable, and complaint handling. They should align medical and commercial activities with approved indications, provide clear education on administration and duration, and support responsible deprescribing conversations through healthcare professionals. Portfolio and supply decisions should account for public procurement, pharmacy distribution, local registration, and contingency planning. Digital and AI investments should begin with narrowly defined, measurable use cases governed by validation, cybersecurity, privacy, and human review. Ongoing monitoring of safety communications, guideline changes, and country-specific requirements is essential.

Methodology: Structured Review of Product, Clinical, and Regulatory Factors

This executive summary uses a qualitative synthesis framework focused on the dosage form, therapeutic role, healthcare delivery context, and operating requirements of esomeprazole magnesium enteric-coated tablets. The assessment organizes considerations by region, multinational group, and country, and examines formulation quality, clinical stewardship, access pathways, supply resilience, pharmacovigilance, and responsible technology adoption. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used. Country-level conclusions are directional and should be validated against current local labels, formularies, regulatory notices, treatment guidelines, and procurement rules.

Conclusion: Responsible Delivery Remains the Core Differentiator

Esomeprazole magnesium enteric-coated tablets occupy an established role in acid-related disease management, but successful delivery depends on more than formulation availability. Consistent quality, appropriate patient selection, adherence support, duration review, pharmacovigilance, and resilient distribution are central priorities across diverse healthcare systems. Regional and country differences require localized regulatory and access strategies, while artificial intelligence can improve oversight when implemented with evidence, accountability, and human control.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Esomeprazole Magnesium Enteric-coated Tablets Market, by Route Of Administration

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral

8. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Strength

  • 8.1. Introduction
  • 8.2. 10 Mg
  • 8.3. 20 Mg
  • 8.4. 40 Mg

9. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Form

  • 9.1. Introduction
  • 9.2. Capsule
  • 9.3. Tablet

10. Esomeprazole Magnesium Enteric-coated Tablets Market, by Application

  • 10.1. Introduction
  • 10.2. Gastroesophageal Reflux Disease
    • 10.2.1. Erosive
    • 10.2.2. Non Erosive
  • 10.3. Peptic Ulcer Disease
    • 10.3.1. Duodenal Ulcer
    • 10.3.2. Gastric Ulcer
  • 10.4. Zollinger Ellison Syndrome

11. Esomeprazole Magnesium Enteric-coated Tablets Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Hospital Pharmacy
    • 11.2.1. Private Hospital
    • 11.2.2. Public Hospital
  • 11.3. Online Pharmacy
    • 11.3.1. E Commerce Platforms
    • 11.3.2. Telepharmacy
  • 11.4. Retail Pharmacy
    • 11.4.1. Chain Pharmacy
    • 11.4.2. Independent Pharmacy

12. Esomeprazole Magnesium Enteric-coated Tablets Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Esomeprazole Magnesium Enteric-coated Tablets Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Esomeprazole Magnesium Enteric-coated Tablets Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Alkem Laboratories Ltd.
  • 16.2. Amneal Pharmaceuticals LLC
  • 16.3. AstraZeneca PLC
  • 16.4. Aurobindo Pharma Ltd.
  • 16.5. Cadila Pharmaceuticals Ltd. (Zydus Cadila)
  • 16.6. Cipla Ltd.
  • 16.7. Dr. Reddy's Laboratories Ltd.
  • 16.8. Glenmark Pharmaceuticals Ltd.
  • 16.9. Lupin Limited
  • 16.10. Sun Pharmaceutical Industries Ltd.
  • 16.11. Teva Pharmaceutical Industries Ltd.
  • 16.12. Torrent Pharmaceuticals Ltd.
  • 16.13. Viatris Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Years Considered for the Study
  • FIGURE 2. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Research Design
  • FIGURE 3. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Research Framework
  • FIGURE 4. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Data Triangulation
  • FIGURE 5. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 7. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2025 vs 2032 (%)
  • FIGURE 9. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2025 vs 2032 (%)
  • FIGURE 11. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 15. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Esomeprazole Magnesium Enteric-coated Tablets Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Esomeprazole Magnesium Enteric-coated Tablets Market Segmentation & Coverage
  • TABLE 2. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 4. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 11. Global 10 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global 10 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global 10 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global 20 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global 20 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global 20 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global 40 Mg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global 40 Mg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global 40 Mg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 21. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 28. Global Gastroesophageal Reflux Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Gastroesophageal Reflux Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Gastroesophageal Reflux Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Erosive Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Erosive Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Erosive Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Non Erosive Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Non Erosive Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Non Erosive Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Peptic Ulcer Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Peptic Ulcer Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Peptic Ulcer Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Duodenal Ulcer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Duodenal Ulcer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Duodenal Ulcer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Gastric Ulcer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Gastric Ulcer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Gastric Ulcer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Zollinger Ellison Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Zollinger Ellison Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Zollinger Ellison Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 50. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global E Commerce Platforms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global E Commerce Platforms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global E Commerce Platforms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Telepharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Telepharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Telepharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 80. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 81. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 82. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 83. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 84. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 85. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 86. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 87. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 89. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 91. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 92. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 93. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 94. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 95. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 96. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 97. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 98. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 99. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 100. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 102. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 103. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 104. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 105. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 106. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 107. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 108. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 109. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 110. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 111. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 113. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 114. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 115. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 116. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 117. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 118. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 119. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 120. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 121. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 122. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 124. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 125. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 126. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 127. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 128. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 129. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 130. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 131. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 132. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 133. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 135. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 136. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 137. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 138. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 139. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 140. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 142. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 143. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 144. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 147. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 148. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 149. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 150. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 151. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 152. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 153. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 156. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 157. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 158. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 159. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 160. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 161. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 162. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 163. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 164. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 165. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 166. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 167. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 168. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 169. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 170. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 171. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 172. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 173. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 174. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 175. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 176. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 177. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 178. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 180. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 181. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 182. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 183. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 184. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 185. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 186. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 187. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 188. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 189. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 190. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 191. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 192. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 193. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 194. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 195. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 196. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 198. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 199. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 200. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 201. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 202. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 203. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 204. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 205. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 206. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 207. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 208. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 209. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 210. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 211. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 212. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 213. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 214. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 215. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 216. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 217. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 218. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 219. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 220. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 221. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 222. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 223. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 224. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 225. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 226. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 227. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 228. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 229. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 230. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 231. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 232. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 233. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 234. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 235. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 236. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 237. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 238. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 239. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 240. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 241. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 242. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 243. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 244. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 245. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 246. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 247. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 248. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 249. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 250. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 251. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 252. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 253. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 254. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 255. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 256. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 257. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 260. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 261. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 262. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 263. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 264. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 265. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 266. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 267. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 268. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 269. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 270. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 271. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 272. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 273. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 274. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 275. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 276. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 277. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 278. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 279. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 280. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
  • TABLE 281. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 282. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 283. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
  • TABLE 284. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
  • TABLE 285. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 286. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
  • TABLE 287. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
  • TABLE 288. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 289. Russia Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
  • TABLE 290. Russia Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Admini